Abstract
COVID-19 is typically a respiratory or lung infection however the SARS-CoV-2 virus has been found to cause blood clots leading to stroke. The World Stroke Organization reported a 5% risk for an ischemic stroke in the setting of COVID-19
Highlights
COVID-19 is typically a respiratory or lung infection the SARS-CoV-2 virus has been found to cause blood clots leading to stroke
Hemorrhagic stroke is not the focus of this case study, it is possible that the affinity of the SARS-CoV-2 virus for Angiotensin-converting enzyme 2 (ACE2) receptors, which are expressed in arterial smooth muscle and endothelial cells in the brain, allows the virus to damage intracranial arteries, causing vessel wall rupture [6]
ACE2 receptors are present in the vascular endothelium which may be a causative factor for thrombotic complications in ischemic stroke [7]
Summary
COVID-19 is typically a respiratory or lung infection the SARS-CoV-2 virus has been found to cause blood clots leading to stroke. COVID-19, Geriatrics, Stroke, Ischemic CVA, SARS-CoV-2, Gerontology, Primary Care, COVID Pneumonitis, Chest CT This case will illustrate the importance of early treatment of COVID-19 in patients with underlying Cardiac Disease and Hypertension in order to help prevent strokes further complicating management and increasing mortality and morbidity.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
